|
STRATEGIC POLICY CHANGE
The forgoing has necessitated a constructive development of inwardly looking corporate operational policies and guidelines that best meet the needs and aspirations of our healthcare and challenges
OUR NEW POLICY DIRECTION IS:
1. To seek business alliances with reputation international pharmaceutical companies with the objective of selectively introducing their useful products into the Nigeria/ECOWAS market.
2. To go into collaborative agreements with local researchers with a view to developing “home grown” drugs for specific aliments in key disease areas that plague our people.
3. To deliberately foray into the manufacturing of affordable branded generics in common disease areas for use in our primary healthcare system.
4. To deliberately encourage, facilitate, and partake in public awareness/advocacy programmes aimed at preventing or eradicating common preventable diseases.
|
